Capstone Downgrades Alere (ALR) as Triage Recall Begins
Tweet Send to a FriendGet Alerts ALR Hot Sheet
Price: $26.20 -0.98%
Rating Summary:
4 Buy, 7 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 10 | Down: 23 | New: 22
Rating Summary:
4 Buy, 7 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 10 | Down: 23 | New: 22
Trade ALR Now!
Capstone Investments' John Putnam downgraded shares of Alere (NYSE: ALR) heading into Wednesday's afternoon session following an earlier SEC filing which disclosed the company has begun its recall of some 104 lots of its Triage products. The analyst now rates the stock a Hold, down from Buy previously. A $32 price target was maintained.
Alere shares are down more than 3 percent to $18.13 at last check.
For an analyst ratings summary and ratings history on Alere click here. For more ratings news on Alere click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Alere shares are down more than 3 percent to $18.13 at last check.
For an analyst ratings summary and ratings history on Alere click here. For more ratings news on Alere click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: UBS Downgrades Carnival (CCL) to Neutral; Worst May Not Be Behind
- Macquarie Downgrades Deutsche Bank (DB) to Underperform
- Jefferies Downgrades First Republic Bank (FRC) to Hold
Create E-mail Alert Related Categories
DowngradesRelated Entities
Putnam Investments, Capstone InvestmentsLogin with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!

